Smith & Nephew plc (LON:SN)
London · Delayed Price · Currency is GBP · Price in GBX 1,123.00
-15.00 (-1.32%)
Jul 21, 2026, 1:39 PM GMT
Smith & Nephew Market Cap
Smith & Nephew has a market cap or net worth of 9.57 billion as of July 21, 2026. Its market cap has decreased by -2.76% in one year.
Market Cap
9.57B
Enterprise Value
11.63B
Revenue
4.58B
Ranking
n/a
PE Ratio
21.39
Stock Price
1,123.00
ChartMarket Cap Chart
Since December 31, 1985, Smith & Nephew's market cap has increased from 819.93M to 9.57B, an increase of 1,067.50%. That is a compound annual growth rate of 6.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 9.57B | -8.94% |
| Dec 31, 2025 | 10.51B | 21.60% |
| Dec 31, 2024 | 8.65B | -7.88% |
| Dec 29, 2023 | 9.39B | -2.72% |
| Dec 30, 2022 | 9.65B | -15.11% |
| Dec 31, 2021 | 11.36B | -14.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 195.34B |
| GSK plc | 76.32B |
| Haleon | 32.88B |
| Convatec Group | 4.24B |
| Hikma Pharmaceuticals | 3.28B |
| HUTCHMED (China) | 1.50B |
| Genus | 1.43B |
| Oxford Nanopore Technologies | 1.10B |